These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 22710792)
21. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer. Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818 [TBL] [Abstract][Full Text] [Related]
22. Review of anal cancer patients at the Ottawa hospital. Abunassar M; Reinders J; Jonker DJ; Asmis T Eur J Surg Oncol; 2015 May; 41(5):653-8. PubMed ID: 25776438 [TBL] [Abstract][Full Text] [Related]
23. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Valentini V; Coco C; Cellini N; Picciocchi A; Rosetto ME; Mantini G; Marmiroli L; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1175-84. PubMed ID: 10613310 [TBL] [Abstract][Full Text] [Related]
24. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal. Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820 [TBL] [Abstract][Full Text] [Related]
25. Aggressive strategy for the treatment of synchronous metastatic anal squamous cell carcinoma. Lupinacci RM; Simon JM; Spano JP; Menegaux F Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):e127-9. PubMed ID: 23958077 [No Abstract] [Full Text] [Related]
26. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571 [TBL] [Abstract][Full Text] [Related]
27. Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma. Kumabe A; Fukada J; Kota R; Koike N; Shiraishi Y; Seki S; Yoshida K; Kitagawa Y; Shigematsu N Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29228166 [TBL] [Abstract][Full Text] [Related]
28. Chemoradiation in rectal squamous cell carcinoma: Bi-institutional case series. Loganadane G; Servagi-Vernat S; Schernberg A; Schlienger M; Touboul E; Bosset JF; Huguet F Eur J Cancer; 2016 May; 58():83-9. PubMed ID: 26974707 [TBL] [Abstract][Full Text] [Related]
29. Squamous Cancers of the Rectum Demonstrate Poorer Survival and Increased Need for Salvage Surgery Compared With Squamous Cancers of the Anus. Kulaylat AS; Hollenbeak CS; Stewart DB Dis Colon Rectum; 2017 Sep; 60(9):922-927. PubMed ID: 28796730 [TBL] [Abstract][Full Text] [Related]
30. Hyperfractionated radiation therapy and concurrent 5-fluorouracil, cisplatin and mitomycin-C in head and neck carcinoma. A pilot study. Abitbol AA; Schwade JG; Lewin AA; Sridhar K; Brandon AH; Markoe AM; Casiano RR; Houdek PV; Serago C; Miller DJ Am J Clin Oncol; 1992 Jun; 15(3):250-5. PubMed ID: 1590280 [TBL] [Abstract][Full Text] [Related]
31. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. Doci R; Zucali R; La Monica G; Meroni E; Kenda R; Eboli M; Lozza L J Clin Oncol; 1996 Dec; 14(12):3121-5. PubMed ID: 8955657 [TBL] [Abstract][Full Text] [Related]
32. Definitive chemoradiotherapy for anal canal cancer: single-center experience. Tachibana I; Nishimura Y; Inada M; Fukuda K; Ishikawa K; Nishikawa T; Yokokawa M; Nakamatsu K; Kanamori S; Hida JI Int J Clin Oncol; 2018 Dec; 23(6):1121-1126. PubMed ID: 29992389 [TBL] [Abstract][Full Text] [Related]
33. The effectiveness of chemoradiation therapy and salvage surgery for hypopharyngeal squamous cell carcinoma. Suzuki K; Hayashi R; Ebihara M; Miyazaki M; Shinozaki T; Daiko H; Sakuraba M; Zenda S; Tahara M; Fujii S Jpn J Clin Oncol; 2013 Dec; 43(12):1210-7. PubMed ID: 24031082 [TBL] [Abstract][Full Text] [Related]
34. Pilot study of FMC (5-fluorouracil, mitomycin C, and cisplatin) with radiotherapy for patients with anal cancer. Lee IH; Lee SJ; Kang BW; Chae YS; Baek D; Hwang S; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Kim JG Cancer Chemother Pharmacol; 2016 Dec; 78(6):1263-1267. PubMed ID: 27830320 [TBL] [Abstract][Full Text] [Related]
37. Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma. El-Hadaad HA; Wahba HA; Roshdy S J Gastrointest Cancer; 2015 Jun; 46(2):156-60. PubMed ID: 25810165 [TBL] [Abstract][Full Text] [Related]
38. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index. Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225 [TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinoma of the rectum: a multimodality approach. Lafreniere R; Ketcham AS J Surg Oncol; 1986 Jun; 32(2):106-9. PubMed ID: 3088332 [TBL] [Abstract][Full Text] [Related]
40. [A Case of Squamous Cell Carcinoma of the Esophagus with Achalasia -- Conversion from Chemoradiotherapy to Surgery]. Morimoto T; Yata Y; Nio M; Yonenaga Y; Hanaki K; Mise M; Higashide S; Kanda Y; Noda H Gan To Kagaku Ryoho; 2016 Apr; 43(4):447-9. PubMed ID: 27220791 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]